Semler Scientific (NASDAQ:SMLR) Reaches New 52-Week High – Here’s What Happened

Semler Scientific, Inc. (NASDAQ:SMLRGet Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $80.74 and last traded at $77.00, with a volume of 259005 shares traded. The stock had previously closed at $74.50.

Semler Scientific Price Performance

The company has a market cap of $538.95 million, a price-to-earnings ratio of 31.72 and a beta of 1.18. The stock has a 50-day moving average price of $45.79 and a 200 day moving average price of $35.45.

Semler Scientific (NASDAQ:SMLRGet Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The company had revenue of $13.51 million during the quarter.

Hedge Funds Weigh In On Semler Scientific

Several hedge funds have recently modified their holdings of SMLR. CWM LLC raised its holdings in shares of Semler Scientific by 486.3% in the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after purchasing an additional 744 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of Semler Scientific by 10.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock worth $709,000 after acquiring an additional 1,940 shares during the last quarter. Rhumbline Advisers raised its stake in Semler Scientific by 27.1% in the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after acquiring an additional 1,320 shares during the period. Quest Partners LLC acquired a new stake in Semler Scientific during the 2nd quarter valued at $59,000. Finally, Meeder Asset Management Inc. acquired a new position in shares of Semler Scientific in the second quarter valued at $67,000. Institutional investors own 49.37% of the company’s stock.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

Recommended Stories

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.